Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02431026 · ClinicalTrials.gov registry record · NA

Temperature Evaluation by MRI Thermometry During Cervical Cooling

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT02431026: Completed NA study, sponsored by University of Vermont.

NCT02431026 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02431026, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

The American Heart Association (AHA) recommends cooling (inducing mild hypothermia) patients who were resuscitated following cardiac arrest but who remained comatose. Induced mild hypothermia is now the standard of care for post-resuscitation patients in the intensive care unit (ICU) setting. The use of cooling has recently moved to pre-hospital and emergency department (ED) application as more current studies show that early initiation of cooling significantly improves neurologic outcomes and survival rates instead of waiting until the patient arrives in the ICU to initiate cooling. In the pre-hospital setting chilled saline (4°C) and packing the body in ice have been the primary methods to initiate induced mild hypothermia The Excel Cryo Cooling System is a non-invasive cervical collar (C-collar) that provides cooling to the carotid arteries, the main blood supply to the brain, and allows for the rapid initiation of selective cerebral cooling. The investigators are planning to use MRI-thermometry to see how quickly the Excel Cryo Cooling Collar can drop brain temperature when applied by itself. Healthy volunteers will be used for this study to provide important temperature data on the effectiveness of the Excel Cryo Cooling System. The investigators will be able to use the data from this project to further the current clinical research in induced mild hypothermia after cardiac arrest.

Primary Outcome

MRI thermometry will be used to evaluate the rate of cooling

Interventions

  • DEVICE Cooling pack activated Excel Cryo Cooling Collar

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2015-04
Est. Completion 2016-07
Phase NA
University of Vermont

162 total trials

What the finished NCT02431026 record still lists

NCT02431026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Cooling pack activated Excel Cryo Cooling Collar is the first listed.

NCT02431026 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02431026 about?

NCT02431026 is a clinical study titled "Temperature Evaluation by MRI Thermometry During Cervical Cooling". The American Heart Association (AHA) recommends cooling (inducing mild hypothermia) patients who were resuscitated following cardiac arrest but who remained comatose. Induced mild hypothermia is now the standard of care for post-resuscitation patients in the intensive care unit (ICU) setting. The us...

What is the current status of trial NCT02431026?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2015-04. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02431026?

The interventions under investigation include: Cooling pack activated Excel Cryo Cooling Collar (DEVICE).

Who is sponsoring clinical trial NCT02431026?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02431026's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02431026, the US trial registry maintained by the National Library of Medicine. NCT02431026 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.